Added to YB: 2021-02-19
Pitch date: 2021-02-19
SLNO [bullish]
Soleno Therapeutics, Inc.
+15.73%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Market Cap
$2.2B
Pitch Price
$45.15
Price Target
N/A
Dividend
N/A
EV/EBITDA
97.60
P/E
105.15
EV/Sales
9.19
Sector
Biotechnology
Category
N/A
Show full summary:
SOLENO THERAPEUTICS INC SLNO
A summary for this pitch has not been created yet.
Read full article (0 min)